HYLORIS PHARMACEUTICALS
Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known pharmaceuticals. Hyloris Pharmaceuticals develop innovative proprietary products that offer significant advantages compared to currently available alternatives.
HYLORIS PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2013-01-01
Status:
Active
Contact:
+32 (0)4 346 02 07
Total Funding:
30 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Corvus Pharmaceuticals
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Meusinvest (Noshaq)
Meusinvest (Noshaq) investment in Venture Round - Hyloris Pharmaceuticals
Saffelberg Investments
Saffelberg Investments investment in Venture Round - Hyloris Pharmaceuticals
Scorpiaux
Scorpiaux investment in Venture Round - Hyloris Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-06 | Pleco Therapeutics | Hyloris Pharmaceuticals investment in Series A - Pleco Therapeutics | 17.3 M EUR |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-05-26 | Hyloris appoints Patrick Jeanmart as Chief Financial Officer |
More informations about "Hyloris Pharmaceuticals"
Our Governance - Hyloris
Prior to her role at 4P, Revital was the Head of PharmaSeed Europe (2013-2014) a research organization specialized in early development where she supervised all BD activities, finance …See details»
Hyloris Pharmaceuticals - Crunchbase Investor Profile …
Hyloris Pharmaceuticals is an innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known …See details»
Hyloris Pharmaceuticals - LinkedIn
Hyloris Pharmaceuticals | 8,381 followers on LinkedIn. We are committed to addressing unmet medical needs through reinventing existing medications | We are a specialty biopharma company focused on ...See details»
Investor Presentation - hyloris.com
This presentation has been prepared by, and is the sole responsibility of, Hyloris Pharmaceuticals SA (the "Company") for discussions with investors in relation to the Company and its group. …See details»
Hyloris Pharmaceuticals Company Description - Stock Analysis
3 days ago Hyloris Pharmaceuticals SA engages in the research, development, and manufacture of pharmaceutical products to address unmet medical needs. The company …See details»
Hyloris releases Annual Report 2024 - Euronext Live
19 hours ago Press Release. Regulated Information Hyloris releases Annual Report 2024 Publication of the Annual Report for Financial Year 2024; Annual Shareholders’ Meeting on …See details»
Hyloris Pharmaceuticals - PitchBook
Hyloris Pharmaceuticals SA is an early-stage specialty pharmaceutical company focused on adding value to the healthcare system by reformulating pharmaceuticals. The company develops proprietary products it believes offer …See details»
Hyloris Pharmaceuticals - Pharmaceutical Companies Database
Locations, phone, website - all information about Hyloris Pharmaceuticals. Regulations. GLOBAL ...See details»
Hyloris Pharmaceuticals - Funding, Financials, Valuation & Investors
Hyloris Pharmaceuticals is registered under the ticker EBR:HYL . Their stock opened with €10.75 in its Jun 29, 2020 IPO. Hyloris Pharmaceuticals is funded by 4 investors. Walloon and …See details»
Kye Pharmaceuticals Partners with Hyloris Pharmaceuticals for the ...
Hyloris Pharmaceuticals SA is a specialty biopharma company focused on innovating, reinventing, and optimizing existing medications to address important healthcare needs and deliver …See details»
Financials – Hyloris
Prior to her role at 4P, Revital was the Head of PharmaSeed Europe (2013-2014) a research organization specialized in early development where she supervised all BD activities, finance …See details»
Hyloris Pharmaceuticals - Contacts, Employees, Board Members, …
Hyloris Pharmaceuticals has 2 current employee profiles, including Chief Business Development Officer , Board Member Thomas Jacobsen. Hyloris Pharmaceuticals has 1 board member or …See details»
Hyloris Pharmaceuticals lists on Euronext Brussels
Jun 29, 2020 Based in Liège, Belgium, Hyloris is an early-stage innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating …See details»
Hyloris Pharmaceuticals Reports 2024 Results and - vfb.be
Hyloris Pharmaceuticals Reports 202. 4 . Results and . P. rovides Business Outlook - Total revenue and Other operating income increased to over €10 million (+138%), fueled by an …See details»
Hyloris Pharmaceuticals - Craft
Hyloris Pharmaceuticals is a company that develops specialty pharmaceuticals intended to add value to patients and the healthcare system. The company specializes in reformulating well …See details»
Careers – Hyloris
Based in Liège, Belgium, Hyloris is an early-stage innovative specialty pharmaceutical company focused on adding value to the healthcare system by reformulating well-known …See details»
Hyloris Pharmaceuticals : Regulated Information Hyloris releases …
19 hours ago Liège, Belgique - 30 avril 2025 - 23h55 CET -- Information réglementée - Hyloris Pharmaceuticals SA (Euronext Brussels : HYL), une société biopharmaceutique spécialisée …See details»
Hyloris Pharmaceuticals - Products, Competitors, Financials, …
Hyloris Pharmaceuticals is a specialty biopharma company that works on reformulating and repurposing existing medications within the healthcare sector. The company provides a …See details»
Hyloris: Revenue, Worth, Valuation & Competitors 2025
About Hyloris. Hyloris is a Pharmaceuticals related company founded in 2013 with 51 employees an estimated revenue of $10.3M, and. It has 10 competitors including Imaging Endpoints, …See details»
Update on Developments Following Completion of Forensic
Hyloris announced on 20 January 2023 that it had successfully concluded agreements regarding (i) the in-licensing by Hyloris from QliniQ V (“QliniQ”) of HY-088 and (ii) the divestment by …See details»